Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-κB in laryngeal squamous cell carcinoma: A potential indicator for poor prognosis

Oncology Reports

Volumn 22, Issue 1, 2009, Pages 89-95

  Huang, Chuang ^a   Huang, Kun ^a   Wang, Chi ^a   Jiang, Zhen Dong ^b   Li, Xing Xing ^a   Wang, Hong Peng ^a   Chen, Hong Yan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Laryngeal squamous cell carcinoma; MKK4; NF B; Prognosis

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR GROWTH; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MAP KINASE KINASE 4; MIDDLE AGED; NEOPLASM STAGING; NF-KAPPA B; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 68249143415     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000410     Document Type: Article

References (25)

1. Dérijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ and Davis RJ: Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 27: 682-685, 1995.
2. Lin A, Minden A, Martinetto H, et al: Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268: 286-290, 1995.
3. Teng DH, Perry WL III, Hogan JK, et al: Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res 57: 4177-4182, 1997.
4. Yoshida BA, Dubauskas Z, Chekmareva MA, Christiano TR, Stadler WM and Rinker-Schaeffer CW: Mitogen-activated protein kinase kinase 4/ stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res 59: 5483-5487, 1999.
5. Yamada SD, Hickson JA, Hrobowski Y, et al: Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res 6: 6717-6723, 2002.
6. Wang L, Pan Y and Dai JL: Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors. Oncogene 23: 5978-5985, 2004.
7. Lee HY, Oh SH, Suh YA, Baek JH, Papadimitrakopoulou V, Huang S and Hong WK: Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer. Clin Cancer Res 11: 6065-6074, 2005.
8. Hayden MS and Ghosh S: Signaling to NF-kappaB. Genes Dev 18: 2195-224, 2004.
9. Luo JL, Kamata H and Karin M: IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 115: 2625-2632, 2005.
10. Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663, 2000.
11. Baldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107: 241-246, 2001.
12. Sethi G, Ahn KS, Xia D, Kurie JM and Aggarwal BB: Targeted deletion of MKK4 gene potentiates TNF-induced apoptosis through the down-regulation of NF-{kappa}B activation and NF-{kappa}B-regulated antiapoptotic gene products. J Immunol 179: 1926-1933, 2007.
13. Wu CW, Li AF, Chi CW, Huang CL, Shen KH, Liu WY and Lin W: Human gastric cancer kinase profile and prognostic significance of MKK4 kinase. Am J Pathol 156: 2007-2015, 2000.
14. Su GH, Hilgers W, Shekher MC, Tang DJ, Yeo CJ, Hruban RH and Kern SE: Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res 58: 2339-2342, 1998.
15. Su GH, Song JJ, Repasky EA, Schutte M and Kern SE: Mutation rate of MAP2K4/MKK4 in breast carcinoma. Hum Mutat 19: 81-84, 2002.
16. Stark AM, Tongers K, Maass N, Mehdorn HM and Held-Feindt J: Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 131: 191-198, 2005.
17. Khatlani TS, Wislez M, Sun M, et al: c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene 26: 2658-2666, 2007.
18. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM and Sonenshein GE: Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100: 2952-2960, 1997.
19. Okano H, Shiraki K, Inoue H, et al: Fas stimulation activates NF-kappaB in SK-Hep1 hepatocellular carcinoma cells. Oncol Rep 10: 1145-1148, 2003.
20. Kojima M, Morisaki T, Sasaki N, Nakano K, Mibu R, Tanaka M and Katano M: Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res 24: 675-681, 2004.
21. Ondrey FG, Dong G, Sunwoo J, et al: Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog 26: 119-129, 1999.
22. Zucchini C, Rocchi A, Manara MC, et al: Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines. Int J Oncol 32: 17-31, 2008.
23. Kourelis K, Sotiropoulou-Bonikou G, Vandoros G, Repanti M, Varakis I and Goumas P: Coordinated upregulation of COX-2 and NF-kappaB is a steady feature of laryngeal carcinogenesis. ORL J Otorhinolaryngol Relat Spec 69: 181-189, 2007.
24. Xia D, Srinivas H, Ahn YH, et al: Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. J Biol Chem 282: 3507-3519, 2007.
25. Lee CK, Lee EY, Kim YG, Mun SH, Moon HB and Yoo B: Alpha-lipoic acid inhibits TNF-alpha induced NF-kappaB activation through blocking of MEKK1-MKK4-IKK signaling cascades. Int Immunopharmacol 8: 362-370, 2008.